Back to Results
First PageMeta Content
Health / Micronucleus test / Pharmaceuticals policy / Regulatory requirement / Mutagen / Micronucleus / Food and Drug Administration / Mutation / Biology / Pharmaceutical sciences


S2A : Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals
Add to Reading List

Document Date: 2013-07-12 14:26:10


Open Document

File Size: 50,49 KB

Share Result on Facebook

City

Ottawa / /

Company

Expert Working Group / ICH Expert Working Group / /

Country

Japan / United States / Canada / /

/

Event

Product Recall / Product Issues / /

Facility

Publications Brooke Claxton Building / /

/

IndustryTerm

pharmaceuticals / exposure media / insoluble pharmaceuticals / pharmaceutical industry / health products / therapeutic product / food / /

MarketIndex

TA 1535 / /

Organization

Health Products and Food Branch / Health Products and Food Branch THERAPEUTIC PRODUCTS DIRECTORATE / Therapeutic Products Directorate / FDA Center / FDA / Food Safety / European Union / Ministry of Health / OECD / Senior Scientific Advisor office of Science Therapeutic Products Directorate Holland Cross / /

Person

Colette F. Strnad / /

/

Position

coordinator / Minister of Health / Minister of Public Works / /

Product

Toxicological Evaluation Guidelines / /

ProvinceOrState

Ontario / /

Technology

Pharmacokinetics / cloning / apoptosis / /

URL

http /

SocialTag